# Sentonix, Inc. — Form D/A

Sentonix, Inc. of ARLINGTON, MA, a company, filed a Form D amendment with the SEC on 2025-05-12. The offering totals $10.5M, of which $6.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-05-12
- Form: D/A
- Accession: 0002039609-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.5M
- Amount sold: $6.5M
- Remaining: $4.0M
- Minimum investment: $10K
- Investors: 15
- Date of first sale: 2024-09-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-525715

## Issuer

- Name: Sentonix, Inc.
- CIK: 0002039609
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1167 MASSACHUSETTS AVE, ARLINGTON, MA, 02476
- Phone: 617-388-6440

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| John Beaver | Director | Redwood City, CA |
| Jack Hoppin | Director | Natick, MA |
| Kenan Turnacioglu | Director | Arlington, MA |
| John Beaver | Executive Officer | Redwood City, CA |
| Karl Schmidt | Executive Officer | Arlington, MA |
| Kenan Turnacioglu | Executive Officer | Arlington, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-10-03](https://search.stillhousedata.com/formd/0001973076-24-000001) | D | $5.5M | $5.2M |

## More

- [CIK 2039609 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2039609&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002039609-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.